| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Orio Therapeutics At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the … Type: | 0 | 0 | 0 | 1 |
 |  Theolytics Transforming patients’ lives | Through world leading science | With a great team Theolytics is a biotechnology company harnessing viruses to combat cancer. A step-change in the oncolytic viral therapy field, our phenotypic screening Platform enables the discovery and development of efficacious, targeted candidates suitable for intravenous delivery and optimised for a chosen patient population. In addition to advancing an internal Pipeline of programs spanning both solid and liquid tumours, we are establishing select strategic partnerships to expand and accelerate pipeline development. Biotech, Oncology, and Virology | 2 | 2 | 0 | 34 |
 |  Fresh Inset S.A. Battling food waste with Vidre+TM technology that protects the freshness & quality of fruits and vegetables. Fresh Inset is a technology company that develops a wide range of solutions for extending the post-harvest shelf-life of fruits and vegetables to reduce food waste and increase profits. The company’s products are based on a revolutionary and patented technology of an innovative formulation of 1-MCP that protects crops from the damaging effect of ethylene during storage, shipment, and at the retail market. Fresh Inset’s products can be applied to all fruits and vegetables at any latitude. They ensure a gradual and timed release … Type: | 1 | 1 | 0 | 19 |
 | Econutri We recycle CO2 for sustainable protein production. We specialize in producing sustainable proteins through the fermentation of organisms that can efficiently utilize CO2, helping to reduce our carbon footprint and promote a healthier planet. Our impact goes beyond sustainable protein production. By utilizing CO2 and green hydrogen to create high-quality proteins, we’re helping to reduce greenhouse gas emissions, decrease land usage for agriculture, and conserve natural resources. Get in touch with us if you want to find out more about the project! Type: | 0 | 0 | 0 | 6 |
 | Sano Genetics Accelerating the world's transition to precision medicine. At Sano, our mission is to accelerate the world's transition to precision medicine. Sano combines genetic testing, recruitment, and long-term engagement in one platform, accelerating enrollment and simplifying operations for precision medicine teams driving breakthroughs for patients. Genetics, Big Data, and Research Type: | 2 | 1 | 1 | 85 |
 | Pelago Bioscience AB Pelago Bioscience Pelago Bioscience AB is founded to accelerate the use and value of the CETSA® technology in Drug Discovery and diagnostics. We know that the need for Target Engagement studies is large and increasing and there is no single technology with the same opportunities to fill this need as CETSA®. We will: - Make more relevant data available to our customers at an earlier stage of the Drug Discovery process - Enable filtering of compounds based on physiologically relevant data to facilitate better decisions in Drug Discovery programs - Provide our customers with CETSA® based Target Engagement data in … Type: | 1 | 0 | 1 | 54 |
 | IO Biotech Break Boundaries. Ignite Change. IO Biotech is a clinical-stage biopharmaceutical company pioneering the first-in-class investigational dual-action immune-modulating cancer vaccine with the goal of becoming the backbone of combination therapy for people with cancer. The Company’s T-win® vaccine platform is directed against the tumor microenvironment (TME) and is designed to stimulate T cells against tumor cells and the most important immune-suppressive cells in the TME. IO Biotech’s most advanced program for IO102-IO103 is currently in Phase 3 development. IO Biotech is headquartered in Copenhagen, Denmark. IO Biotech has achieved a proven track record of progressing compounds to the clinic, and has … Type: | 0 | 0 | 0 | 77 |
 | Lightcast Profiling function, cell by cell Lightcast is developing a novel, droplet-based platform that provides a deeper understanding of cellular function. Compared to standard microfluidic methods, the Lightcast platform offers the ability to run a broader range of assays and to precisely control and track the number, occupancy, location, and movement of each droplet. The unprecedented scalability and flexibility of this approach will help advance translational and basic research as well as streamline development workflows for drugs, therapeutics, and applied biologics. Type: | 0 | 0 | 0 | 108 |
 | Bactolife Empowering worldwide health through a fortified gut microbiome We are on a mission to enhance global gut health and support the fight against antimicrobial resistance. As a Danish biotech firm, we're pioneering the future of gut health with our unique ingredients, Binding Proteins. These breakthrough Binding Protein ingredients, natural and versatile enough for any food, beverage, or supplement, selectively bind and block harmful microbial activity without disturbing the beneficial microbiome—a truly revolutionary approach. Our products are specially formulated for diverse needs, benefiting everyone from mothers and children to the elderly, immune-compromised individuals, travelers, and even animals. Backed by investors such … Type: | 3 | 1 | 2 | 53 |
 | Cytomos Predictive analytics for bioprocessing and cell therapies Providing predictive analytics from suspended-cells through our unbiased cytometry technology, AuraCytTM Type: | 1 | 0 | 1 | 27 |
 | ENOUGH Making More with Less ENOUGHs purpose to ‘make protein sustainable’. Using fermentation to meet future food protein needs is widely recognised as the most effective solution to feed a growing planet. ENOUGH produces ABUNDA® mycoprotein, a complete food ingredient containing all essential amino acids as well as being high in dietary fibre. It is versatile and can be made into alternative/vegan meat, seafood and dairy products. The company will supply ABUNDA as a B2B (business to business) food ingredient to consumer brands and retailers, addressing the need for high scale supply of healthy and sustainable protein to address a rapidly … Type: | 3 | 2 | 1 | 82 |
 | Bitome Better tools, faster science Bitome is a Boston-based life sciences tools company that uses metabolomic insights to drive efficient biomanufacturing. Bitome's magnetic-resonance/neural-network-driven platform provides quantified analysis of the cell culture environment -- enabling bio-based products to get to market faster. Our mission at Bitome is to enable the bioeconomy with purpose made tools, so join us as we de-risk industrial biology. Magnetic Resonance, synthetic biology, continuous monitoring, metabolic analysis, lab automation, instrumentation, MEMS, microfluidics, and machine learning Type: | 0 | 0 | 0 | 2 |
 |  NanoGenics Nanogenics is an innovative, research-based biotechnology company that specialises in developing bespoke, peptide-based vectors for gene therapy. Nanogenics is proud to introduce LipTideTM; an exciting custom-built delivery vehicle that can be modified to target different cell types and deliver different payloads for all gene therapy. LipTideTM is a peptide nanoparticle that has already shown excellent in vivo efficacy across a range of models and delivery routes, including nebulised and systemic administration. The peptide component performs two functions: it binds the payload to form the core of the nanoparticle and it also triggers receptors on target cells, which cause the cell … Type: | 0 | 0 | 0 | 1 |
 | NeoNeuro APTAMARKERS: Diagnostic fingerprints in blood for pathology detection NeoNeuro has developed a new scientific approach named Aptamarkers. In the past, biomarkers for the diagnosis of diseases have been developed based on an understanding of the disease and the effect of the disease on the regulation of proteins or metabolites. This approach is time-consuming and expensive as experimental hypothesis regarding the pathophysiology of the disease must be tested and progressively built upon. NeoNeuro set out to develop a new platform with the capacity to screen all epitopes that are present in blood. We are not only screening all molecules in blood … Type: | 1 | 1 | 0 | 2 |
 | SMARTOX Smartox Biotechnology is specialized in peptide research and manufacturing Smartox Biotechnology is specialized in peptide research and engineering. Peptide synthesis, physiology, pharmacology, neuroscience, ion channel research, toxin, venomous animals, and screening library Type: | 0 | 0 | 0 | 7 |
 | dianosic "Smartly designed for you" Dianosic ambitions to become a leading company in solving challenges in patient’s adherence to medication. We provide an alternative to daily medication by designing a unique sustained intranasal drug delivery solution for respiratory and chronic central nervous system diseases. Dianosic aims to fight against debilitating chronic diseases that affect millions of people. Our first focus is on chronic allergic rhinitis and chronic rhinosinusitis. Currently, 85% of allergic rhinitis patients are not compliant with their treatment. Furthermore, 20% to 25% of patients do not respond to first-line treatments. These medical challenges significantly impact patient’s quality of life. … Type: | 11 | 4 | 2 | 13 |
 | AZELEAD An innovative drug discovery technology Good morning and welcome, we are pleased to introduce you to our structure. AZELEAD has developed ZebraScreen and ZebraTox, an innovative methodology for rapid and accurate assessment of the efficacy and toxicity of a drug In the past few years, we have seen a lot of attrition in the development of new drugs, with a failure rate of nearly 84% attributed to the low benefit of efficacy / toxicity. Three therapeutic areas are mainly affected by this decrease: oncology (failure rate of 29.5%), neurology (failure rate of 14%), and infectious diseases (failure … Type: | 0 | 0 | 0 | 5 |
 | Mablink Bioscience Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D Type: | 15 | 9 | 10 | 35 |
 | CARBIOS Biotechnology powering plastic and textile circularity Carbios SA is a green chemistry company that focuses on discovering and developing enzymatic bioprocesses applied to plastic and textile polymers. The Company creates a new generation of fully biodegradable plastics with a controlled lifespan, a process enabling infinite biorecycling of plastic waste (PET) and a new biological pathway for the production of competitive biosourced polymers. Bioplasturgie, Biodégradation, Biorecyclage, Economie circulaire, Innovation, and Enzymes Type: | 42 | 14 | 28 | 141 |
 | Microbiotica Microbiotica identifies gut bacteria linked to phenotype with unprecedented precision in order to discover and develop live bacterial therapeutics and biomarkers from clinical datasets. Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics … Type: | 5 | 1 | 1 | 56 |
 | CN Bio Generate human-specific efficacy and safety data with PhysioMimixTM Single- and Multi-organ Microphysiological Systems. CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to improve the accuracy and efficiency of preclinical drug discovery. Our PhysioMimix® suite of microphysiological systems, 3D-validated cells, consumable plates, and Contract Research Services facilitate the prediction of human responses to drug exposure, in the presence or absence of disease, so that new medicines can be brought to market more rapidly, cost-effectively and using fewer animals. Utilizing primary cells, our perfused single (Lung, Liver), and multi-organ (Intestine/Liver, Lung/Liver) models recapitulate the microarchitecture, microenvironment and function of … Type: | 4 | 2 | 4 | 46 |
 | Congenica Driving Precision Medicine Congenica is a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. We drive Precision Medicine and help reduce the burden on healthcare systems by delivering automated analysis, diagnosis and treatment solutions to healthcare providers and patients worldwide. Congenica’s Platform is the only product of its kind that has received the CE Mark under the In Vitro Diagnostics Directive for both rare diseases and somatic and inherited cancer, and is uniquely placed to drive ubiquitous use of complex data in routine clinical care. Our products and services are consolidated … Type: | 0 | 0 | 0 | 68 |
 | Mission Therapeutics Mission Therapeutics is a private, drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat diseases of high unmet need. Mission has built a world-leading platform for the discovery and development of first-in-class, small-molecule drugs that selectively target deubiquitylating enzymes (DUBs) – an emerging, and hitherto intractable, drug class that is attracting significant commercial interest as the potential ‘Next Kinase Area’. Mission’s DUB platform is yielding a rich pipeline of novel therapeutics for the benefit of patients across therapeutic areas. Mission’s strategy is to create value by advancing its pipeline programmes through early clinical development, and preferentially … Type: | 6 | 2 | 5 | 38 |
 | Bionomous Bringing automation to the lab Bionomous - the world's first provider of AI-powered solutions for screening, sorting and dispensing of small biological entities. We are an innovative, agile and conscious team of biologists and engineers working to provide you with an easy-to-use and customizable solution to free up valuable time and increase efficiency. Our patented technology was originally created to enable the mechanical sorting of zebrafish eggs. Now, we have adapted this technology to other small biological entities, such as Xenopus laevis oocytes and embryos, killifish and medaka eggs and even flower seeds. Type: | 2 | 1 | 2 | 22 |
 | Celtic Renewables Leading the green chemical revolution Celtic Renewables patented technology converts low-value byproducts, residues and waste into high-value green chemicals which directly displace chemicals made from gas and oil in the manufacturing process and lower the carbon footprint of everyday products like skin creams, nail varnish, household cleaning products, paints, medicines and vitamins. Type: | 4 | 1 | 3 | 52 |
 | Levity Crop Science Ltd Improving crop production with pioneering chemistry Levity Crop Science develops sustainable agricultural inputs. Levity's products help farmers produce more and better crops, with less resource, helping move agriculture around the world towards sustainability. Levity branded products are available through distributors. We also help incorporate our technology into third party products for out multinational partners - helping them to produce better products. Levity specialise in nutrient use efficiency (making fertilisers work better and at lower rates), and crop stress tolerance (helping crops grow better when the weather and soil is bad). Fertlilisers, Biostimulants, Biopesticides, and Crop Science Type: | 1 | 0 | 0 | 8 |
 | F-star, an invoX company A clinical-stage biopharma developing next gen bispecific antibodies to transform the lives of patients with cancer. F-star, an invoX company, is a clinical-stage biopharmaceutical business pioneering bispecific antibodies in immunotherapy so more people with cancer can live longer and improved lives. F-star is committed to working towards a future free from cancer and other serious diseases through the use of tetravalent (2+2) bispecific antibodies to create a paradigm shift in treatments. F-star has four second-generation immunooncology therapeutics in the clinic, each directed against some of the most promising IO targets in drug development, including LAG-3 and CD137. F-star’s proprietary antibody … Type: | 5 | 1 | 2 | 65 |
 | INFEX Therapeutics Vital new drugs for pandemic infections We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections. Pharmaceuticals, R&D, Antimicrobial Resistance, and Development Type: | 3 | 0 | 0 | 20 |
 | Oncimmune We understand disease through the lens of the immune system for more effective, safer treatments & better diagnosis Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based platform, delivers actionable insights into therapies to our pharmaceutical and biotech partners. Oncimmune’s ImmunoINSIGHTS platform enables life-science organisations to optimise drug development and delivery, leading to more effective targeted as well as safer treatments for patients. Oncimmune is headquartered in the UK, with a discovery research centre in Dortmund, … Type: | 5 | 0 | 4 | 49 |
 | uFraction8 Scalable, efficient bioprocessing uFraction8 builds products around a disruptive new liquid particle processing technology. Following our world leading research, establishing new levels of throughput for massively multiplexed microfluidic devices, our technology will be the key to unlock a prosperous and sustainable future. Our technology offers superior performance and cost savings against the big three liquid processing technologies of filtration, flow centrifugation and flocculation. High volume applications benefit by our unique ability to granularly match targeted volumetric throughputs and our ability to scale this beyond the physical limitations of competing technologies. Maintaining an unobstructed flow path allows our technology to continue … Type: | 7 | 1 | 5 | 6 |
 | Emergex Vaccines A UK biotechnology company developing T cell-priming immune set-point candidates against infectious diseases. Emergex, a clinical-stage, privately-held biotechnology company headquartered in Abingdon, UK, with an operating subsidiary in Doylestown, Pennsylvania, USA, is pioneering the development of 100% synthetic T cell-priming immune set-point vaccine candidates that harness and direct the body’s natural CD8+ T cell immune response to destroy and clear pathogen-infected cells in order to provide protection against some of the world’s most urgent health threats. First indications pursued are against infectious diseases caused by: [i] viruses, amongst which are Betacoronavirus, Dengue Fever and Universal Influenza A, including pandemic influenza, … Type: | 1 | 0 | 1 | 38 |
 | Sophion Bioscience Pioneering Ion Channels Sophion was founded in the year 2000 by a group of passionate electrophysiologists, all having the shared purpose of making patch clamping objective and independent of user skills to provide faster, more accurate and objective patch clamping results. “To take the voodoo out of patch clamping”. Over the past twenty years, we have developed from a startup into a global organization, but the passion and drive to provide high-performance patch clamp solutions persist. With our complete technical, biological and application support we help our partners to achieve their targets, and through the continued development of our QPatch … Type: | 1 | 0 | 1 | 97 |
 | Bavarian Nordic For us, it is all about improving and saving lives Improving and saving lives through innovative vaccines is at the heart of what we do in Bavarian Nordic, and we have more than 25 years of experience in developing life-saving vaccines. We are a fully integrated vaccine company focused on the development, manufacturing and commercialization of our vaccines, and our vision is to become one of the largest pure play vaccine companies in the world. We are a global leader in smallpox and mpox vaccines, which have been developed through our long-standing partnership with the U.S. Government to enhance the … Type: | 2 | 1 | 2 | 1,311 |
 | MorphoSys Driven by our mission: More life for people with cancer. We do not just develop and deliver innovative medicines. We bring together ambitious, collaborative and courageous people who are committed to finding ways to treat cancer differently. MorphoSys began as a research and development technology provider 30 years ago, which positioned us as a valuable partner to pharmaceutical manufacturers worldwide. This empowered our evolution into a fully integrated biopharmaceutical company, and our growth over the past 15 years can only be attributed to the dedicated and passionate people driving our mission forward: More life for people with cancer. For additional … | 9 | 2 | 4 | 617 |
 | BRAIN Biotech AG Developing a biobased future is our passion. Industrial biotechnology is our business. BRAIN Biotech AG is a leading European supplier of biobased products and solutions such as enzymes and proteins, microbial production strains, natural compounds and biotechnological solutions for more sustainable industrial processes. We focus on the fields of nutrition, health and environment. BRAIN Biotech AG is the parent company of the international BRAIN Biotech Group. The Group's business activities are divided into the segments BioProducts, BioScience and BioIncubator. The BioProducts segment comprises the product business with specialty enzymes and other proteins, for which the Group operates fermentation facilities in … Type: | 3 | 1 | 1 | 186 |
 | Kane Biotech Inc. Kane is actively advancing technologies and products that break up biofilms and destroy bacteria. With 81 patents and patents pending, Kane Biotech is Kane Biotech is THE Biofilm Company. Creating smarter ways to fight bacteria, Kane is leading the advancement of technologies and products that break up biofilms and destroy bacteria. Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. StrixNBTM, DispersinB®, AledexTM, bluestemTM, bluestem®, silkstemTM, goldstemTM, coactiv+TM, coactiv+®, DermaKBTM and DermaKB BiofilmTM are trademarks of Kane Biotech Inc. The Company is listed on the TSX … Type: | 0 | 0 | 0 | 22 |
 | Biospace Lab Imaging for discoveries Molecular Imaging in Real Time Biospace Lab - originally Biospace Mesures - was founded in 1989 by Nobel Prize winner Georges Charpak to provide fellow researchers in biology with innovative imaging tools based on his discoveries in high-energy physics and particle detection. Since then, Biospace Lab has pursued and created strong links with medical, pharmaceutical and scientific communities to bring relevant and creative solutions to biomedical imaging needs. Today, Biospace Lab range of instruments, developed with patented technologies, is dedicated to high-performance imaging for pre-clinical research in drug discovery and biology. Biospace Lab instruments and software are … Type: | 2 | 0 | 2 | 13 |
 | XENOTHERA A Xenotherapy platform with embedded technology that renovates immunological treatments XENOTHERA is a biotechnology company based 21 rue La Nouë Bras de Fer, 44000 Nantes, France. Type: | 25 | 3 | 28 | 28 |
 | Oncodesign Services A leading CRO in drug discovery and preclinical services Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. Founded in 1995, Oncodesign Services mission’ is to contribute to the discovery of innovative therapies with unmet medical needs, in particular in oncology, inflammation and infectious diseases. From target identification, hit-to-lead and lead optimization to IND filing, Oncodesign Services support the R&D programs of customers globally (whether pharmaceutical companies, biotechs, public research institutions, etc.). Oncodesign Services offers a full spectrum of services in medicinal chemistry, DMPK, pharmaco-imaging, bioanalysis, in vivo/In vitro pharmacology (including humanized models). This … Type: | 12 | 8 | 5 | 20 |
 | S-Biomedic NV Life science company focused on skin health. Development of Pro- and Post-biotic ingredients from true skin commensals. S-Biomedic is a life science company focused on skin health by pioneering the development of Pro- and Post-biotic ingredients from true skin commensals. S-Biomedic delivers: • novel active ingredients for use in cosmetic formulations • unique positioning & skin benefits • clinically substantiated efficacy claims S-Biomedic is changing the paradigm in skincare and dermatology by unleashing the natural power of your skin microbiome capitalizing on its breakthrough proprietary technology platform and expertise to deliver novel solutions for a wide variety of skin conditions. … Type: | 1 | 1 | 0 | 22 |
 | AMSlab Group of biotechnology companies working in the pharmaceutical, clinical, food and veterinary sectors Our business group is made up of biotechnological companies facilitate Analytical Services. Currently we are present in the pharmaceutical, clinical, veterinary, and food sectors. It also has production plants for standards and kits for these sectors. Clinical, Veterinaria, Estandares, CertifiedMaterialsReference, DrugDiscovery, BPL, GLP, health, clinicaltrials, Manufacturing, Pharmacy, CRO, R&D, MassSpectrometry, GMP, Veterinary, CMO, CMC, Bioanalysis, Biopharmaceuticals, and Omics | 1 | 1 | 0 | 30 |
 | Episome Biotechnologies Less chemicals, More biology! Episome Biotechnologies is a biotechnology company that was founded as a research&development laboratory. Episome Biotech focuses on industrial enzyme technologies. We aim to provide sustainable and environment friendly products for biogas, textile, leather, paper, starch, detergent, rubber and biofuel industries. Industrial Enzymes, Bioenergy, Biogas, and Renewable Energy Type: | 1 | 0 | 1 | 11 |
 | Aether We're building the post-scarcity future. Aether’s mission is to build a future of abundance for the human race. We believe that the machinery of nature can be reverse engineered to manufacture any arrangement of atoms desired, enabling the production of new products anywhere on earth. Type: | 0 | 0 | 0 | 39 |
 | Shivom Next generation genetic data sharing & analytics for the next generation of precision medicine pioneers. We are a London-based healthcare data analytics & AI company, building the world’s largest genetic & precision medicine data marketplace. Our blockchain and AI-based platform solves several problems the global research community faces (e.g. siloed data, cross-border data sharing, lack of state-of-the-art analytic tools, GDPR-compliance) by providing a next-generation data sharing- & data analytics ecosystem, lifting precision medicine, drug discovery, and translational research into a new era of democratized healthcare. We provide an epidemic preparedness platform; a trusted global data exchange & AI analytics eco-system … Type: | 3 | 0 | 3 | 13 |
 | Solar Foods We are introducing a game-changing natural protein for the global food industry. #NextGenEU #NextGenerationEU Solein is a game-changing protein for the global food industry. Produced from air – CO2, water, nitrogen – and electricity, our unique natural single-cell proteins are not dependent on agriculture, weather or the climate. Creating the future of sustainable food with an unlimited diversity of proteins. #NextGenEU #NextGenerationEU Type: | 15 | 3 | 10 | 40 |
 | Theseus Pharmaceuticals Theseus is developing best-in-class kinase inhibitors to shape the future of targeted oncology. Theseus Pharmaceuticals is passionately committed to outsmarting cancer resistance. Cancer is constantly mutating, allowing it to evade initially effective oncology treatments. Theseus believes we can predict how cancer will change, enabling new therapies to stay ahead of future mutations and overcome the demonstrated burden of treatment resistance. Led by a team of pioneers in the discovery and development of tyrosine kinase inhibitors (TKIs), we are developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology. PLEASE NOTE: All open positions for Theseus Pharmaceuticals will be … Type: | 0 | 0 | 0 | 31 |
 | Athelas Digital tools made for modern healthcare organizations. At Athelas we're bringing simple, life-changing health care products and medical billing services to patients and providers around the globe. Athelas Revenue Cycle Management (RCM): Billing and reimbursement don't have to be painful. Athelas RCM delivers world-class service, maximizes reimbursements, and delivers actionable insights into the financial health of your practice. Athelas prides itself on end-to-end revenue cycle management. This means we cover all aspects of RCM besides simple submission - include denials, working A/R, research, and more as the backbone of your healthcare business. Athelas has powered revenue intelligence for hundreds of … Type: | 1 | 1 | 0 | 333 |
 | Neuralink Neuralink is developing ultra-high bandwidth brain-machine interfaces to connect humans and computers. Neuralink is a team of exceptionally talented people. We are creating the future of brain-machine interfaces: building devices now that will help people with paralysis and inventing new technologies that will expand our abilities, our community, and our world. Our goal is to build a system with at least two orders of magnitude more communication channels (electrodes) than current clinically-approved devices. This system needs to be safe, it must have fully wireless communication through the skin, and it has to be ready for patients to take home and … Type: | 4 | 1 | 0 | 442 |
 | Amiroy [Automatic translation follows] Innovative Biomaterials AMIROY develops environmentally friendly solutions derived from biological sources to support agricultural production. AMIROY has developed a patented technology thanks to which it is today it is possible to fuse natural polymers such as polypeptides with materials organic and trace elements, to create tailor-made biostimulants adapted to each type of plant. These biostimulants greatly outperform conventional biostimulants in terms of effectiveness, and they also resist washing. Organic Agriculture, Biotechnology, and Biomaterials Type: | 11 | 9 | 9 | 2 |
 | Rhenovia Pharma RHENOVIA Pharma is a French biotech company founded in 2007 by an international team comprising executives of the big pharmaceutical industry and world experts in the fields of neurosciences and modeling of the nervous system. In less than 5 years, Rhenovia became a biosimulation world leader in CNS. Its worldwide unique modeling technology makes it possible to reproduce on computers the cellular and molecular mechanisms of the brain and the neuronal transmission. Rhenovia uses its technology to create computational models that simulate the condition of healthy persons or affected by pathologies of the nervous system (Alzheimer, Parkinson, epilepsy, schizophrenia, depression). … Type: | 0 | 0 | 0 | 3 |
 | mYXpression Digital bio-solutions designed to support the development of biomedicines and optimize their prescription. mYXpression is an innovative French company positioned in the field of health innovation. The company, specialized in R&D, develops innovative tools to assist in the prescription of biomedicines. Its first tool, the RITI® RA test, provides a personalized report specific to the patient by indicating an efficacy score for each biotherapy. This brand new approach provides numerous useful insights to the doctor by assisting in the prescription of biotherapy in order to increase the patient's chances of remission. bio-numérique, innovation technologique, big data, bio-technologie , biotherapie, intelligence … Type: | 18 | 4 | 17 | 8 |
 | MilliDrop Every Droplet Counts Harnessing its millifluidic technologies, MilliDrop develops and markets systems for microbiology applications that incubate, analyze and handle thousands of hundred-nanoliter-scale samples in parallel. Given the Analyzer’s compact nature, the effectiveness of dropletbased cultivation, and the option of integrating this technology into an automated process, MilliDrop can meet the needs in three segments of the global biological instrument and reagent market : Research, Industrial microbiology & Diagnostic À partir de ses technologies millifluidiques, MilliDrop développe et commercialise des automates pour la microbiologie qui permettent d’incuber, d’analyser et de manipuler des milliers d’échantillons d’une centaine de nanolitres en parallèle. … | 0 | 0 | 0 | 6 |
 | Loop Dee Science [Automatic translation follows] Tests you can trust! Making molecular biology faster and more accessible! Created in 2017 and based in Caen in Normandy, Loop Dee Science is a DNA expert start-up that makes molecular biology diagnosis more accessible to the greatest number of users. Our know-how is based on the use of amplification technology and the creation of tools allowing the automation of these tests. We develop and manufacture rapid, reliable and simple genetic analysis kits for the field for the detection of pathogen DNA and RNA. Molecular biology, Field analysis kits, Veterinary kits, Research and development, and PCR Type: | 6 | 2 | 4 | 9 |
 | SYNAXYS Accelerate drug development for neurological diseases SYNAXYS is French biotech specialized in the characterization of the response of the nervous system for nutraceutic, pharmaceutic and veterinary applications. We offer a complete range of R&D services to support drug development, from defining the dose effects in a human model, to identify biological targets and action mechanism, acute and chronic toxicity, or comparison to established treatments. Our field of application: - Drug positioning - Therapeutic evaluation in a diease model - Neuro-oncology - Data generation for IA modeling Neuro-engineering, Neuronal diseases modeling, Neuro-oncology, Autism, Alzheimer disease, and Glioblastoma Type: | 2 | 0 | 2 | 2 |
 | INNOVHEM Innovative science to improve the health of patients To adress the unmet need to dispose of relevant tools to value the efficacy of treatments for red blood cell disorders, INNOVHEM has developed two important and unique innovations :a simple and accurate method to quantify fetal hemoglobin in each red blood cell and a specific new method to measure intravascular hemolysis. Together with several generic biological assays, INNOVHEM offers a comprehensive and innovative platform that supports the development of new treatments for red blod cell pathologies, from preclinical to phase IV evaluation. Type: | 9 | 2 | 8 | 5 |
 | Groupe Chadasaygas / Méthajoule [Automatic translation follows] Méthajoule is a young, dynamic SME specializing in carrying out territorial projects for the valorization of biomass through an anaerobic digestion process. The company has developed an innovative and inclusive collective methanization model based on the specificities of territories, particularly rural ones in the mid-mountains. The methanization units created are of medium size with powers of 300 kWe to 500 kWe. Our projects offer industrial valorization of local resources (livestock effluent, green waste, etc.) with technology specific to the company and correlated to the typology of the material deposit present in areas with a strong agricultural dominance. … Type: | 0 | 0 | 0 | 8 |
 | AELIS FARMA A clinical stage biotech company opening a new frontier in pharmacology Aelis Farma is a clinical-stage biopharmaceutical company specializing in the development of treatments for brain diseases. Aelis Farma is developing a new class of drugs: Signaling Specific inhibitors of the CB1 receptor (CB1-SSi) of the endocannabinoid system that provide access to several therapeutic areas without available treatments. These unique drug candidates, by reproducing a recently discovered natural defense mechanism of the brain , appear to be able to treat various brain pathologies without disrupting normal behavior. A first in pharmacology. Two initial drug candidates are already in clinical trials … Type: | 6 | 2 | 4 | 27 |
 | Olgram marine-inspired molecules to fight immunological diseases Olgram is a biotechnology company developing first-in-class, proprietary immunotherapies to treat immune deficiencies, beginning with immuno-depression after traumatic brain injury and concussion. Biotechnologie, immunologie, antibiorésistance, and commotions | 1 | 1 | 0 | 4 |
 | BforCure Advanced molecular analysis technologies to harness the power of the microbiota. To be more responsive, more efficient and make better decisions, BforCure allows public and industrial stakeholders to access biological information in real time, thanks to an innovative technology of rapid biodetection. Type: | 1 | 0 | 1 | 43 |
 | Micropep Technologies Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins. Type: | 13 | 7 | 5 | 50 |
 | GREEN IMPULSE [Automatic translation follows] Value, protect, nourish Green Impulse is a French start-up which develops new biocontrol solutions for agriculture and is committed to reducing the use of pesticides. Tags: FrenchTech2030 Type: | 20 | 9 | 11 | 17 |
 | Faircraft Faircraft develops a highly sustainable, lab-grown alternative to animal leather. Faircraft develops a highly sustainable, lab-grown alternative to animal leather, based on advanced tissue engineering and material science techniques. Tags: FrenchTech2030 Type: | 5 | 5 | 0 | 12 |
 | mjn-neuro Quality of life for people with epilepsy mjn-neuro is a company dedicated to the design, manufacture and commercialization of medical devices with the aim of improving people's quality of life. All this activity is accompanied by an important policy of reinvestment of resources in R&I and social action. The first device that mjn-neuro is developing is mjn-SERAS: an earpiece that assesses the risk of epileptic seizures. The product consists of the earpiece and an app, which are connected to each other via Bluetooth. The earpiece is customised for each user. The main function of the earpiece is to send a … Type: | 10 | 1 | 8 | 22 |
 | GoodGut Enhancing digestive health GoodGut is a biotechnology company focused on researching and developing analysis systems and therapeutic products to improve the diagnosis and treatment of digestive diseases based on intestinal microbiota. We aim to provide technological tools that will help to obtain a faster, more reliable and lower cost medical diagnosis than existing methods, alongside therapies to improve the quality of life of patients with compromised digestive health. The company was created in 2014 as a spin-off of the University of Girona (UdG) and the Institute of Biomedical Research of Girona Dr. Josep Trueta (IdIBGi). Our facilities can be found … Type: | 4 | 1 | 2 | 14 |
 | Amadix Early cancer detection in blood AMADIX is a leading molecular diagnostics company focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. The mission of the company is extending people's lives, developing disruptive technologies to detect the tumor years in advance, before the symptoms appear. Biotechnology, Cancer Diagnostics, Innovation, Personalized medicine, Blood test, and Biomarkers | 18 | 3 | 13 | 38 |
 | Zymvol Biomodeling Accelerating enzyme discovery and design through computer simulations Yes, we know: changes can be tough. Going from the usual chemical process at your company to an improved biochemical one can be a pain. Where to start? What are the roadblocks? Is all this hassle worth it? The transition to Green Chemistry should be exciting. Not the headache it is today. That’s why at Zymvol we make it easy. 💡 How? By taking care of all the difficult steps towards the bio-journey: from initial discovery of promising reactions to designing a tailor-made enzyme and delivering it to you. Zymvol is a … Type: | 4 | 4 | 2 | 34 |
 | Kimitec Bioinnovation that cares🌱 Kimitec is a biotechnology company applied to agriculture that offers radically innovative natural solutions that are as successful as synthesic chemistry, allowing for a balance between productivity, sustainability, and health preservation. Plant Nutrition, Plant Protection, Biopesticides, Biostimulants, Agriculture, Biotechnology, agricultura, biotecnología, bioestimulantes, biopesticidas, and investigación Type: | 7 | 0 | 3 | 285 |
 | AELIX Therapeutics Developing novel vaccines to cure HIV infection AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen. Type: | 2 | 1 | 1 | 6 |
 | Made of Genes [Automatic translation follows] Personalized Health for healthy people 🧬🩸 Personalized Health for healthy people 💯 Improve your state of health with your 100% individualized habit change program, 100% adapted to you and what makes you unique 📝We provide you with rigorous and easily actionable recommendations curated by our team of health professionals, with which you will achieve real results and maximize your state of health. Healthcare, Personalized Medicine, High Performance Computing, Privacy, molecularhealthcare, digitalhealth, personalizedhealth, and healthcaretransformation Type: | 14 | 1 | 12 | 17 |
 | Enzymlogic Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery. We use exquisitely tuned assays to deliver accurate, robust and reproducible kinetic data of the highest quality that enhances the identification of compounds with the greatest therapeutic potential. The insight … Type: | 1 | 0 | 1 | 12 |
 | BioExpert Network Revolutionise science with your knowledge The BioExpert Network, or BEN, is an exclusive network of experts in the sectors of health, biotechnology, life science and investment. Members have the opportunity to access and evaluate funding proposals for innovative research and development projects before anyone else, and help shape the future of life science and medicine. Proposals which receive the most positive evaluations, in terms of innovation, scientific validity, team and business potential have the opportunity to progress to a crowdfunding campaign with Capital Cell, the first online investment platform in Europe specialized in health and biotechnology. PhD level scientists, physicians, … Type: | 1 | 0 | 1 | 247 |
 | Flomics Liquid biopsies with cell-free RNA. A revolutionary tool for diagnosis, prognosis and patient stratification. Flomics is developing novel blood-based diagnostic tools for a broad range of complex diseases. Our proprietary technology accurately identifies pattern changes in the circulating long RNA molecules of patients. With deep learning algorithms we identify RNA changes associated with disease states in a faster, cheaper and non-invasive way. transcriptomics, circulating RNA, liquid biopsies, fluids transcriptomics, artificial intelligence, genome, diagnostics, and genomics Type: | 2 | 0 | 1 | 20 |
 | Nostrum Biodiscovery Rethink and Accelerate Let's imagine a company that is able to speed up and increase the accuracy of the studies prior to the commercialization of pharmaceutical and biotech products. A young enterprise based on front line research, specialized in cutting-edge bioinformatics and ready to apply supercomputing power to the prediction of drug-target interactions and to the optimization of enzymes involved in biotechnological processes. A company devoted to solve issues related to drug discovery, precision medicine and industrial enzymology. Rethink and accelerate, that’s what NBD is about. We estimate that our approach can definitely reduce the early-stage drug development by up … Type: | 10 | 0 | 5 | 44 |
 | Epithelix Provider of cells, 3D tissues and testing services. Epithelix Sàrl is a Swiss biotech company specialized in human tissue engineering. Epithelix provides innovative R&D solutions for the study of human respiratory diseases (e.g. Asthma, COPD, Cystic Fibrosis, etc.) and for inhalation toxicity testing of chemicals, while reducing the number of animal experiments. Human pulmonary toxicology, Preclinical Drug Development, and Human Tissue Reconstitution Type: | 0 | 0 | 0 | 17 |
 | PVS | 1 | 0 | 1 | 157 |
 | CIMTI Centre per a la Integració de la Medicina i les Tecnologies Innovadores de Catalunya The Center for the Integration of Medicine and Innovative Technologies in Catalonia (CIMTI.cat) is a project focused on the generation of high impact in the health and social field on the basis of developing disruptive and incremental initiatives, of internationals scope, with the ultimate goal of improving the life quality of citizens and the positioning of Catalonia in terms of innovation in the European context. Type: | 6 | 1 | 4 | 12 |
 | Stem Genomics Next generation quality control for cell therapy Stem Genomics provides dedicated services to assess the genetic integrity of human stem cells. We help research scientists with specific assays and recommended workflows for the cell type they work with. Our flagship testing solution, iCS-digitalTM PSC, has revolutionized in-process genomic stability testing in hPSCs thanks to its high precision, ease and speed. It is particularly interesting for regularly monitoring stem cell lines in culture as well as for screening large numbers of clones, e.g., CRISPR-edited clones or human iPSC clones after reprogramming. We can also perform the following tests for you: G-Banding … Type: | 2 | 1 | 1 | 12 |
 | SEQENS In Vitro Diagnostic SEQENS In Vitro Diagnostic | Blood fractionation for IVD | Located in Limoges (France), H2B manufactures fractionated blood products for the life sciences and IVD industries. Thanks to over 20 years of experience, the company has developed a considerable expertise in blood fractionation, extraction and purification. H2B offers a wide range of products including BSA and bovine fibrinogen on the one hand, human sera and plasma on the other. Visit our website for more informations and to find the complete listing of products (www.h2b.fr). in vitro diagnostic and blood fractionation | 0 | 0 | 0 | 10 |
 | Samdoc Medical Technologies Digitize the medical gaze. We are recruiting 👍and fundraising 📈 Samdoc is a startup creating medical decision support tools and based in Caen. Type: | 4 | 2 | 2 | 2 |
 | Phost'in Therapeutics Unmask Cancer, Elicit Immune Response Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases. A new and innovative player in the field of Glyco-Immuno-Oncology, Phost’in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response. Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors. Glyco Immuno Oncology Type: | 11 | 5 | 7 | 15 |
 | LenioBio Rapid eukaryotic, cell-free protein expression that scales for research, development and production. At LenioBio, we develop efficient, robust and sustainable technologies to disrupt the way medicines and food are produced for those in need, wherever they are. Unconstrained by the limitations of cells, we combine our proprietary protein technology with machine learning to significantly accelerate innovation cycles in life science industry. Protein Expression, Protein Production, Synthetic Biology, Biotechnology, Membrane proteins, Antibodies, Functional Proteins, Sustainable Foods, Vaccines, Therapeutic Proteins, Structural Biology, Cell-free protein production, Cell-free protein expression, and Plant-based protein Type: | 7 | 1 | 6 | 48 |
 | 64x Bio An evolution in cell line engineering. High throughput engineering of cell lines to enhance the design and manufacture of next-generation therapeutics. Gene therapy, Synthetic Biology, Genome Engineering, and Functional Genomics Type: | 1 | 1 | 0 | 20 |
 | Epiminder Epiminder is a medical device company developing the next generation brain monitoring technology. The company’s first product, the MinderTM system, is an implantable EEG monitoring system designed to detect epileptic seizures. Through long term and continuous EEG measurements, the system will provide unparalleled insights into brain activity, significantly improving the diagnosis and management of epilepsy and helping people with epilepsy take back control of their lives. Epilepsy is complex neurological condition which affects over 80 million people worldwide, 30% of whom don’t respond to medication. The MinderTM system consists of a small implant placed just under the scalp, a multi-channel … Type: | 0 | 0 | 0 | 22 |
 | Nemosia At Nemosia, we develop 1st in class radiopharmaceuticals for early detection of neurodegenerative disorders. We aim to raise public awareness of neurological disorders and promote a culture where it is seen as normal and safe to do regular brain check-ups even if there are no visible symptoms. | 0 | 0 | 0 | 3 |
 | Beyond Leather Materials ApS We are creating a plant-based and truly sustainable leather alternative from upcycled apple waste. Beyond Leather is a B2B supplier of Leap, a next-gen material made from leftover apples. We upcycle the apple waste from the juice and cider industry to create Leap, with an up to 89% bio-based composition. Today, it is positioned to be the next-gen material, tailored to cater to a range of industries, spanning from small leather goods to the automotive industry. The result is a beautiful, leather-like material with a supple texture. Leap is now available for commercial use. For samples, please visit our website. … Type: | 0 | 0 | 0 | 15 |
 | Neogene Therapeutics Pushing the frontier by pioneering next-generation engineered T cell receptor therapies for solid cancers Neogene Therapeutics is a global, clinical-stage biotechnology company pioneering the discovery, development, and manufacturing of next-generation engineered T cell receptor (TCR) therapies targeting a broad spectrum of solid cancers. With offices in Santa Monica, CA and Amsterdam, the Netherlands, Neogene is aiming to change the paradigm of treatment for solid cancers. Neogene is a member of the AstraZeneca Group. Type: | 1 | 0 | 1 | 164 |
 | XING Technologies XING Technologies has a clear vision in applying diagnostic nanotechnologies to globally enhance healthcare systems. We are an Australian-owned and operated cancer pathology lab that uses genetic sequencing to inform doctors and patients about precision cancer treatment options. Precision medicine offers cancer patients therapy options that are targeted specifically to their cancer. XING Genomic Services offers a range of cancer genetic tests for both newly diagnosed cancer patients and patients dealing with a recurrence of their disease. The results analysed in our lab will determine whether the genetic alterations found in your cancer match genetic changes that are associated with … Type: | 0 | 0 | 0 | 3 |
 | PrimeCell Advanced Therapy, a.s. [Automatic translation follows] PrimeCell Therapeutics is a Czech biotechnological company focused on the field of regenerative medicine and modern therapy, whose goal is to develop and manufacture Advanced Therapies Medicinal Products that improve people's quality of life. The company PrimeCell Therapeutics was founded in 2007 with the aim of building globally competitive hi-tech centers in the Czech Republic, which will participate in the global process of development of modern cell therapy. PrimeCell Therapeutics enables doctors and patients with new treatment methods that use human cells and new materials, such as nanomaterials, to treat serious diseases. Thanks to its unique know-how … Type: | 0 | 0 | 0 | 16 |
 | beone technologies [Automatic translation follows] beone generates health and well-being through high-tech solutions for some of the biggest challenges in medicine. beone is dedicated to generating health and well-being, through high-tech solutions for some of the biggest challenges in medicine. Today we have an innovative, accessible, effective and quick resource for treating the Diabetic Foot condition, which affects more than 100 million people worldwide. With our products and methods, we were able to completely close wounds that had been open for more than 2 years without showing improvement in between 15 and 90 days. Our solution is more efficient than any other … | 0 | 0 | 0 | 2 |
 | Endotelix Diagnostics Ltd We Bring Innovation to APS Care Endotelix is a privately held Swiss biotech start-up company and a spin-off from the University of Geneva. Endotelix is dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome, including diagnostic tests and therapies. diagnostics, Biotech, APS, and LFA Type: | 0 | 0 | 0 | 1 |
 | Kairos Biotech Ltd R&D company focusing on transplant theranostics. Research and development of transplant diagnostics and immunotherapy solutions targetting transplantation tolerance. | 0 | 0 | 0 | 4 |
 | UgenTec Sample Flow Intelligence UgenTec is a molecular laboratory software provider servicing molecular labs, assay and instrument providers globally across applications in Clinical Molecular Diagnostics, Veterinary health, Crop Science, Breeding and Seed Health. UgenTec is headquartered in Hasselt, Belgium with offices in Boston, MA and its FastFinder platform has a global installed base of over 100 molecular labs and partnerships with leading molecular diagnostics vendors. FastFinder is a modular, clinical grade Software as a Service platform using AI methods allowing labs of all sizes to standardize and automate their molecular workflows. FastFinder’s modules include Analysis, Genotyper and Workflow. PCR data analysis, … Type: | 1 | 0 | 1 | 13 |
 | VitroLabs Inc Harnessing science and nature to cultivate authentic materials starting with slaughter-free cultivated leather. We cultivate authentic materials without compromise,by harnessing science and nature responsibly by partnering the most innovative minds in science and technology with the finest craftspeople to accelerate the use of cellular agriculture for good. Our first product is slaughter-free, real leather. cellular agriculture, tissue engineering, leather, luxury leather, lab-grown, cultivation, Bioprocessing, and bioreactor Type: | 1 | 0 | 1 | 24 |
 | Core Biogenesis The future of recombinant protein bioproduction. Growth Factors for Cell Culture. The future of recombinant protein bioproduction. Type: | 9 | 6 | 2 | 42 |
 | Urban Algae [Automatic translation follows] URBAN ALGAE installs algofarms which it operates by promoting microalgae in urban areas. We are committed to preparing a more fertile ground for future generations by taking the bet of microalgae. By deploying our production tools, we will supply companies and consumers engaged in the ecological transition with new products. By developing multi-sectoral projects and local sectors ranging from production to consumption, we too are actively engaged in the ecological transition. Type: | 0 | 0 | 0 | 2 |
 | Tridek-One We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseases Tridek-One is a spin-off from Inserm that develops first-in-class therapeutic agonistic monoclonal antibodies targeting immune checkpoint inhibitory receptors for the treatment of autoimmune and inflammatory diseases. The company primarily focuses on the research and development of first-in-class anti-CD31 agonistic modalities designed to restore the immune balance. Anti-CD31 agonistic mAbs have the potential to provide targeted immunomodulatory activity with a favorable safety profile in diseases with high unmet clinical need. Tridek-One has initiated a discovery program which targets another ITIM receptor, fully leveraging its understanding of inhibitory checkpoint receptor … Type: | 0 | 0 | 0 | 17 |
 | Primaa Primaa develops AI-based software for histological diagnoses, improving a vital step in the detection of cancer. Primaa develops artificial intelligence-based software for automated and accurate histological and cancer diagnoses. digital pathology, histopathology, artificial intelligence, and image analysis Type: | 11 | 2 | 10 | 30 |
 | Minos Biosciences Revolutionary single-cell analysis solution for fundamental, applied and clinical research and diagnostic. Minos Biosciences is on the path to bridge molecular and cell biology in a manner never achieved before that will, in turn, allow scientists to uncover the full picture of cell diversity and dynamics. By combining multi-omics analysis with phenotypic analysis at cell resolution and at high throughput, Minos’ solution provides a new paradigm in single-cell analysis that will open up new frontiers in life science research, precision medicine and diagnostics. Type: | 9 | 1 | 9 | 14 |
 | Les truffieres du berry [Automatic translation follows] #adopteunchêne (truffle tree) Largest French cooperative for the production of black truffles (Tuber Melanosporum) in organic farming. #adoptunchene Black truffle, Traceability, Organic Agriculture, Terroir, Gastronomy, 2.0, Biodiversity, CSR, Environmental Charter, Geology, Soil Chemistry, Microbiology, and History Type: | 2 | 0 | 0 | 1 |
 | Onima Creating super-ingredients from brewer's yeast, leveraging the power of upcycling to build the foods of tomorrow. From Waste ___ to Wonder We strive to reveal the treasures in what others deem obsolete ✨ Onima is committed to creating more resilient ways of production at the heart of our food systems by unlocking all the potential of upcycled goods. Our journey started with the production of a super-ingredient obtained from upcycled brewer’s yeast through a unique debittering process 🍻 Type: | 15 | 11 | 7 | 26 |
Startup